Webinar: Cell Therapies for Parkinson’s Disease from Discovery to Clinic

Return to CIRM Meetings and Events

        

CIRM / Regenerative Medicine Consortium (RMC)

Cell Therapies for Parkinson’s Disease from Discovery to Clinic

Presentations from FDA and Leading Experts

A Webinar was held on November 14th, 2013

 

Webinar Presentation Links

• Watch recording of webinar
• Download speakers’ slide presentations
  • Wilson Bryan slides [pdf]
  • Jeffrey Kordower slides [pdf]
  • Sheryl Osborne slides [pdf]
• Download printed summary of the Q&A session here

WEBINAR AGENDA & TOPICS

Moderator:

• Ellen Feigal, MD, Senior Vice President of Research and Development, CIRM

Expert Speakers:

• Wilson Bryan, M.D., Director, Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)
• Jeffrey Kordower, Ph.D., Professor of Neurological Sciences and Neurology, Rush University Medical Center
• Sheryl Osborne, Consultant in Regulatory Affairs and Clinical Development

Topics that were covered:

The focus of this webinar was on Parkinson’s Disease – using the Lessons Learned to overcome the challenges as cell based therapies move from discovery to the clinic.

• Presentation by FDA – Considerations for first-in-human clinical trials of cell therapies for Parkinson’s Disease
• Lessons learned from human fetal transplants and from gene therapy
• State of preclinical research with hESCs and hiPSC cell therapies
• Questions and Answers

Resources:

• CIRM Parkinson’s Disease Workshop White Paper Report [pdf]
• CIRM’s Parkinson’s Disease Fact Sheet
• Podcast: Whatever Happened to Stem Cells? The Michael J. Fox Foundation

 

 

 

 

 

---